Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
about
Targeting BMP signalling in cardiovascular disease and anaemiaBMPR2 spruces up the endothelium in pulmonary hypertensionWhole-Genome Sequencing of Native Sheep Provides Insights into Rapid Adaptations to Extreme Environments.Structure of Gremlin-1 and analysis of its interaction with BMP-2BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisMicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertensionHypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer.Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report.BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration.MxA Is a Novel Regulator of Endosome-Associated Transcriptional Signaling by Bone Morphogenetic Proteins 4 and 9 (BMP4 and BMP9)Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium-Sensing Receptor.The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertensionHypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension.Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.Update in Pulmonary Vascular Disease 2015.Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertensionDasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.Loss of PPARγ in endothelial cells leads to impaired angiogenesis.The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells.Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implications.Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Lung Circulation.BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.The expression of Smad signaling pathway in myocardium and potential therapeutic effects.Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep.Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation.Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.Reply to "Bone morphogenetic protein's contribution to pulmonary artery hypertension".Baicalin attenuates monocrotaline-induced pulmonary hypertension through bone morphogenetic protein signaling pathway.Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.Mutual interaction between endothelial cells and mural cells enhances BMP9 signaling in endothelial cells.Genome methylation and regulatory functions for hypoxic adaptation in Tibetan chicken embryos.Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular Endothelium.Why we should care about the mysteries of pulmonary hypertension.A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.Catching a Disease: A Molecular Trap as a Therapy for Pulmonary Arterial Hypertension.
P2860
Q26783734-018FBA5D-6793-4859-8628-9D7E47C54477Q26786834-9D4FD846-B088-426D-BE3E-9288A463F58BQ27325750-81FE3E18-7BC8-4535-AB01-D7027557B276Q30090218-5E785F23-9284-428A-92AA-38148B3FCC7FQ31038854-48BB962F-D6FE-415D-A2D3-18530AF7717FQ32884516-567D1D09-CB17-4828-BC53-C669E9EFCFA7Q33580827-6A2690B0-B4E5-4B47-9467-760E528252F9Q33618605-25B0F39F-B391-4C15-A1D9-0ED365DA87BAQ35902174-43A77891-6704-4BFA-A371-1313F867AED6Q36102528-833FF759-D4DC-45FE-8F3C-5067A084941BQ36201107-E9CA9783-E117-4F2D-A8C6-65CA6BA63AB1Q36318985-CE3ACE2C-47CF-4734-9D1F-271FCD1B8835Q36457064-8D2350BE-7BD3-4F33-94E7-A3198C3E7B53Q36568290-3F4A2BA2-CCC7-466B-A97C-6A7A7EBE7C74Q36769101-0859B505-8DDF-4027-990E-834FE665039DQ37013164-EBC6355D-7447-4106-A909-64B6800DC304Q37217460-F05E1384-07D1-4922-A911-6DACECC5953CQ37217507-EDE2094E-C09F-4A61-8872-E15A35D0209AQ37413074-DCE167C8-EB4A-4854-8FDB-4BBE4EB47FE7Q38265566-7B1E578E-C4F5-406F-BBFE-512A5F449313Q38642429-7D3B4ABF-AB24-40FD-9DBD-CB8FBED72895Q38690162-83B16731-E796-44FE-9510-5338895CC763Q38736112-BC6F1245-62A5-411D-898C-4A7F2AF0B09BQ38779774-E6BB5652-2CE2-4554-B1E7-465C92CDA363Q38804579-00100249-F85C-47A7-B4EC-CA1F4D4B3B14Q38817806-FD7AAA59-647B-437A-8D5C-E8FC8208D007Q39008931-66029108-64E1-44DA-A3B5-D4DA017BAA94Q39329860-66733D79-A9BE-40E0-8310-62DF6CECD7AAQ39760107-E4830E3A-9E9B-4159-B1B7-7420AA03AED2Q40999521-0688F56D-F096-418B-AD82-B0579D5BCAE2Q41484602-65B0A365-EA5F-486F-B167-04662A9FE916Q41660197-34760470-950B-4C0E-82AC-2557E3723108Q42039588-B5B42687-4DC0-4D38-A3AD-9E397DF5B33CQ42112003-E7E260C8-AEF9-471D-9868-B2B636287269Q42114336-2494E75A-BF77-4961-8A67-56CA17DEEF39Q42269669-CA6D61D9-E9A5-4552-9B81-73EDFD83FD72Q42370494-3B0782F8-01BC-4D1D-8976-640880C170FDQ42396141-6D4F2737-51C6-4F2B-806E-6811DE4F052DQ42752955-D2EA4620-E2C3-4BA7-9BA6-8E0DE44C905EQ42752968-BD84494B-EF1A-40C5-8121-07035EB7866D
P2860
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selective enhancement of endot ...... lmonary arterial hypertension.
@ast
Selective enhancement of endot ...... lmonary arterial hypertension.
@en
type
label
Selective enhancement of endot ...... lmonary arterial hypertension.
@ast
Selective enhancement of endot ...... lmonary arterial hypertension.
@en
prefLabel
Selective enhancement of endot ...... lmonary arterial hypertension.
@ast
Selective enhancement of endot ...... lmonary arterial hypertension.
@en
P2093
P2860
P50
P356
P1433
P1476
Selective enhancement of endot ...... lmonary arterial hypertension.
@en
P2093
Bernd Kinzel
Janine M Wilkinson
Kylie M Drake
Lai Ming Yung
Matthias Mueller
Micheala A Aldred
Paul D Upton
Stephen D Moore
Xudong Yang
P2860
P2888
P304
P356
10.1038/NM.3877
P407
P577
2015-06-15T00:00:00Z